AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial
logo

CASI(Delisted)

CASI Pharmaceuticals·NASDAQ
--
--(--)
3.84 / 10
Neutral

Fund-flow metrics are encouraging, scoring 6.67/10. Medium-sized inflows show a positive trend, hinting at underlying buying interest. Analyst coverage is limited to one ‘Strong Buy’ rating from HC Wainwright & Co., but the historical win rate for this analyst is only 0% over the recent 20 days, tempering enthusiasm. Sentiment is neutral, and overall capital movement is not yet decisively bullish.

FundamentalSentiment(3.84)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-09-03
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate0.0%